These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1834180)

  • 1. Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes.
    Jost S; Reuner C; Geiger J; Mohadjer M; Milios E; Cramer H
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):109-12. PubMed ID: 1834180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
    Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
    J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
    Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
    Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid levels of immunoreactive substance P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease.
    Rösler N; Reuner C; Geiger J; Rissler K; Cramer H
    Peptides; 1990; 11(1):181-3. PubMed ID: 1692993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in chronic pain patients.
    Urban BJ; France RD; Bissette G; Spielman FJ; Nemeroff CB
    Pain; 1988 May; 33(2):169-172. PubMed ID: 2967947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-like immunoreactivity in cerebroventricular fluid of patients with basal midline tumours.
    Cramer H; Weigel K; Rissler K; Milos A; Wolf A; Mundinger F
    Neurol Res; 1987 Sep; 9(3):205-10. PubMed ID: 2891071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
    Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
    Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man.
    Maeda K; Yasuda M; Kaneda H; Maeda S; Yamadori A
    Neuropeptides; 1994 Dec; 27(6):323-32. PubMed ID: 7898640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular size distribution of somatostatin-like immunoreactivity in the cerebroventricular fluid of neurosurgical patients.
    Rissler K; Jost S; Mohadjer M; Mundinger F; Cramer H
    Neurosci Res; 1987 Jun; 4(5):343-56. PubMed ID: 3670743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term high frequency transcutaneous electrical nerve stimulation (hi-TNS) in chronic pain. Clinical response and effects on CSF-endorphins, monoamine metabolites, substance P-like immunoreactivity (SPLI) and pain measures.
    Almay BG; Johansson F; von Knorring L; Sakurada T; Terenius L
    J Psychosom Res; 1985; 29(3):247-57. PubMed ID: 2411923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P-like immunoreactivity and analgesic effects of vibratory stimulation on patients suffering from chronic pain.
    Guieu R; Tardy-Gervet MF; Giraud P
    Can J Neurol Sci; 1993 May; 20(2):138-41. PubMed ID: 7687513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin-like immunoreactivity in cerebrospinal fluid of patients with complex partial epilepsy.
    Pitkänen A; Jolkkonen J; Aikiä M; Sirviö J; Sivenius J; Riekkinen PJ
    Eur Neurol; 1988; 28(1):1-5. PubMed ID: 3366146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective evaluation of pain in various spinal diseases: neuropeptide immunoreactivity in the cerebrospinal fluid.
    Imasato H; Nagata K; Hashimoto S; Komori H; Inoue A
    Spinal Cord; 1997 Nov; 35(11):757-62. PubMed ID: 9392047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.
    Cramer H; Rissler K; Rösler N; Strubel D; Schaudt D; Kuntzmann F
    Eur Neurol; 1989; 29(1):1-5. PubMed ID: 2468498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc.
    Lindh C; Liu Z; Lyrenäs S; Ordeberg G; Nyberg F
    Scand J Rheumatol; 1997; 26(6):468-72. PubMed ID: 9433409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease.
    Cramer H; Wolf A; Rissler K; Weigel K; Ostertag C
    J Neurol; 1985; 232(4):219-22. PubMed ID: 2864402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variation of substance P-like immunoreactivity in plasma and cerebrospinal fluid in the course of arthritis induced by Freund adjuvant in rats, a model for the study of chronic pain].
    Calvino B; Maillet S; Pradelles P; Besson JM; Couraud JY
    C R Acad Sci III; 1991; 312(8):427-32. PubMed ID: 1905187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular fluid neuropeptides in Parkinson's disease. II. Levels of substance P-like immunoreactivity.
    Cramer H; Jost S; Reuner C; Milios E; Geiger J; Mundinger F
    Neuropeptides; 1991 Feb; 18(2):69-73. PubMed ID: 1708113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
    J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid somatostatin in delirium.
    Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
    Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.